Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.2K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

579
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
579
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

6.3K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.1K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the role of parental decision-making and quality of clinical care in under-5 mortality in Western Kenya: an application of the Three Delays model.

BMC health services research·2026
Same author

Post-mortem characterisation of pathogen-specific causes of infection-related deaths in African and south Asian neonates: a prospective, observational, multicentre study.

The Lancet. Infectious diseases·2026
Same author

Assessing safety in the RTS,S/AS01 malaria vaccine implementation programme: an overview and comparison of methods.

Malaria journal·2026
Same author

Deaths with preceding hospitalisations within 180 days in eight countries in sub-Saharan Africa and South Asia: A secondary descriptive analysis of the Child Health and Mortality Prevention Surveillance (CHAMPS) network.

BMJ open·2026
Same author

Country-specific estimates of misclassification rates of computer-coded verbal autopsy algorithms.

BMJ global health·2026
Same author

Post-mortem characterisation of HIV-associated under-5 deaths in the CHAMPS network: population-based mortality surveillance.

The lancet. HIV·2026

Related Experiment Video

Updated: Mar 12, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K

Community-acquired bacterial meningitis.

Diederik van de Beek1, Matthijs Brouwer1, Rodrigo Hasbun2

  • 1Department of Neurology, Center of Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, P.O. BOX 22660, 1100DD Amsterdam, The Netherlands.

Nature Reviews. Disease Primers
|November 4, 2016
PubMed
Summary
This summary is machine-generated.

Bacterial meningitis, a serious brain infection, is caused by bacteria like Streptococcus pneumoniae. New vaccines and treatments are crucial due to rising drug resistance and evolving bacterial strains.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells
10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

Published on: July 14, 2020

2.8K

Related Experiment Videos

Last Updated: Mar 12, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells
10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

Published on: July 14, 2020

2.8K

Area of Science:

  • Infectious Diseases
  • Neurology
  • Microbiology

Background:

  • Meningitis involves inflammation of the meninges and brain, posing significant global health challenges.
  • Community-acquired bacterial meningitis, primarily caused by Streptococcus pneumoniae and Neisseria meningitidis, leads to high mortality and morbidity.
  • While vaccines for Haemophilus influenzae type b exist, ongoing research targets common meningitis pathogens.

Purpose of the Study:

  • To review the current understanding of bacterial meningitis pathogenesis.
  • To discuss advancements in vaccines and treatment strategies for bacterial meningitis.
  • To highlight the impact of drug resistance and serotype shifts on meningitis management.

Main Methods:

  • Review of experimental and genetic association studies on bacterial meningitis pathogenesis.
  • Analysis of treatment outcomes with early antibiotics and corticosteroids.
  • Evaluation of existing and developing vaccination programs.

Main Results:

  • Streptococcus pneumoniae and Neisseria meningitidis are key pathogens, necessitating targeted vaccines.
  • Early antibiotic therapy improves outcomes, but drug resistance is a growing concern.
  • Corticosteroids show benefit in high-income settings, contingent on bacterial species.

Conclusions:

  • Further improvements in bacterial meningitis outcomes depend on host inflammatory response modulation and preventive strategies.
  • Development of novel vaccines is essential to combat evolving bacterial meningitis strains and resistance.
  • Integrated approaches combining vaccination, early treatment, and host-targeted therapies are critical for reducing meningitis burden.